Evaluation of vitamin A, E and C supplement therapy on immunologic profiles of pulmonary tuberculosis patients

M. Mirsaedi, S. Mohammadian, A. Ostad Rahimi, J. Baghdadchi, S. D. Mansouri, S. Shaghasempour, A. A. Velayati (Tehran, Islamic Republic Of Iran)

Source: Annual Congress 2005 - Biological and treatment aspects of tuberculosis
Session: Biological and treatment aspects of tuberculosis
Session type: Poster Discussion
Number: 2908
Disease area: Respiratory infections

Congress or journal article abstract

Abstract

Introduction:
There are several reports about micronutrients effects in infectious diseases. Vitamin could affect immunity system especially cell mediated immunity. In this study we evaluated them role in Immunologic profiles of pulmonary tuberculosis (TB) patients. Method:
The documented smear positive pulmonary TB patients had divided to two groups randomly. All were adult (> 15 year) and had not suffered of any accompanied immuno- depressive disease.
First group received Vitamin A, E, C and Anti-TB drugs.
Second group had no other mediations except anti-TB.
Flowcytometry for CD3, CD4, CD8, CD14, CD16+56 and HLA – DR were done before treatment and after end of 2 moths in all groups.
Data was collected and analyzed by SPSS soft ware.
Results:
35 patients divided in groups (15 in Vitamin A,E,C and 20 in control group). Mean (±SD) age were 51.4± 18.5 and 52± 18 years in case and control group respectively.(P=.97)
There were significant differences (before and after) assay in all folwcytomtric profiles in both group except in CD8, HLA-DR, CD19.
CD8 had significant differences only in case group.
HLA-Dr and CD19 had not any changes in case and control groups.
Conclusion:
Vitamin therapy with A, E and C could not alter flowcytometric Profiles in TB patients. Of course we need investigate more.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Mirsaedi, S. Mohammadian, A. Ostad Rahimi, J. Baghdadchi, S. D. Mansouri, S. Shaghasempour, A. A. Velayati (Tehran, Islamic Republic Of Iran). Evaluation of vitamin A, E and C supplement therapy on immunologic profiles of pulmonary tuberculosis patients. Eur Respir J 2005; 26: Suppl. 49, 2908

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of vitamin D replacement in the tuberculosis patients
Source: Annual Congress 2012 - Tuberculosis: clinical findings I
Year: 2012


Plasma level of vitamin A, E and C before and during pulmonary TB treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 644s
Year: 2005

Evaluation of the effect of Category I anti tuberculous therapy on the vitamin D status of pulmonary tuberculosis patients
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019


Vitamin C levels in Indian patients with active pulmonary tuberculosis
Source: Annual Congress 2010 - Tuberculosis: metabolic insights
Year: 2010


Evaluation of vitamin A supplement-therapy on immunologic profiles of pulmonary tuberculosis patient
Source: Eur Respir J 2005; 26: Suppl. 49, 655s
Year: 2005

Investigation of vitamin D receptor gene variants in Iranian patients affected with pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 654s
Year: 2005

Outcome of vitamin A & zinc supplementation in the treatment of smear positive pulmonary tuberculosis patients
Source: Annual Congress 2007 - Clinical tuberculosis
Year: 2007


Vitamin E supplement usage and pulmonary outcomes in COPDGene
Source: International Congress 2016 – Asthma, COPD, and ACOS: physical activity, dietary aspects, and diseases burden
Year: 2016

Correlation between vitamin D receptor polymorphism with clinical and nutritional status in intensive phase treatment of pulmonary tuberculosis
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016


Diet related vitamin D deficiency and reactivation of tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 416s
Year: 2004

Vitamin D levels in patients with active TB: Is it clinically relevant?
Source: International Congress 2018 – Challenges in tuberculosis care
Year: 2018

Are we effectively monitoring and treating vitamin D deficient patients with tuberculosis?
Source: Annual Congress 2013 –Tuberculosis susceptibility: genetic polymorphism and vitamin D deficiency
Year: 2013

The relationship of vitamin D binding protein polymorphisms with blood vitamin D Level in Korean patients with COPD
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015

The relationship between vitamin D deficiency and the main characteristics of COPD patients
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020


Adjunctive vitamin D in tuberculosis treatment: meta-analysis of individual participant data
Source: Eur Respir J, 53 (3) 1802003; 10.1183/13993003.02003-2018
Year: 2019



Serum level of vitamin D3 before and after treatment in pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: clinical findings I
Year: 2012


Effect of vitamin A & zinc supplementation on clinical response &nutritional status in patients with tuberculosis getting standard chemotherapy: a double blind, placebo control study in Bangladesh
Source: Eur Respir J 2004; 24: Suppl. 48, 722s
Year: 2004

Serum vitamin C level in patients with acute pneumonia and in COPD patients before and after therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 38s
Year: 2006

Vitamin D deficiency and COPD exacerbations: Effect of vitamin D supplementation
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015

Clinical impact of vitamin D deficiency on Tunisian asthmatics
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017